Climb Bio (CLYM) Stock Chart & Stock Price History $1.94 +0.06 (+3.19%) As of 10/15/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Climb Bio Stock Price Performance The Climb Bio (CLYM) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 7.78%. In the past month, the stock has decreased 3.48%, reflecting recent market activity. As of the latest close, Climb Bio traded at $1.94 with a market cap of $131.45 million and volume of 633,871 shares. Receive CLYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+7.78%1 Month Performance-3.48%3 Month Performance+38.57%Year-To-Date Performance+7.78% CLYM Stock Chart for Thursday, October, 16, 2025 CLYM Chart by TradingView Climb Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$1.88$1.94+3.19%$1.95$1.80633,871 shs$131.45 million10/14/2025$2.00$1.88-6.00%$2.04$1.881.60 million shs$127.39 million10/13/2025$1.80$2.00+11.11%$2.01$1.82597,995 shs$135.53 million10/10/2025$1.89$1.80-4.76%$1.92$1.78550,135 shs$121.98 million10/09/2025$1.80$1.89+5.00%$1.95$1.73787,280 shs$128.07 million10/08/2025$1.65$1.80+9.09%$1.83$1.66593,481 shs$121.97 million10/07/2025$1.81$1.65-8.84%$1.85$1.541.61 million shs$111.81 million10/06/2025$1.98$1.81-8.59%$2.06$1.80704,686 shs$122.65 million10/03/2025$2.04$1.98-2.94%$2.12$1.951.54 million shs$134.17 million10/02/2025$1.97$2.04+3.55%$2.05$1.96380,300 shs$138.23 million Get the Latest News and Ratings for CLYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$2.01$1.97-1.99%$2.03$1.94345,549 shs$133.50 million09/30/2025$1.99$2.01+1.01%$2.04$1.96386,120 shs$136.20 million09/29/2025$2.13$1.99-6.57%$2.21$1.97433,142 shs$134.84 million09/26/2025$2.10$2.13+1.43%$2.21$2.02351,257 shs$144.33 million09/25/2025$2.19$2.10-4.11%$2.18$2.06336,933 shs$142.30 million09/24/2025$2.25$2.19-2.67%$2.28$2.18189,594 shs$148.39 million09/23/2025$2.32$2.25-3.02%$2.36$2.23283,273 shs$152.46 million09/22/2025$2.31$2.32+0.43%$2.44$2.24529,086 shs$157.21 million09/19/2025$2.24$2.31+3.12%$2.44$2.25832,808 shs$156.54 million09/18/2025$2.12$2.24+5.66%$2.24$2.12361,778 shs$151.78 million09/17/2025$2.01$2.12+5.47%$2.19$2.02567,871 shs$143.65 million09/16/2025$2.04$2.01-1.47%$2.06$1.98422,917 shs$136.21 million09/15/2025$2.25$2.04-9.33%$2.29$2.03665,394 shs$138.23 million Related Companies Fulcrum Therapeutics Stock Chart Ocugen Stock Chart Esperion Therapeutics Stock Chart Organogenesis Stock Chart ADC Therapeutics Stock Chart Inhibrx Biosciences Stock Chart CryoPort Stock Chart Solid Biosciences Stock Chart Rapt Therapeutics Stock Chart Astria Therapeutics Stock Chart Receive CLYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLYM) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
